Anika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20
07 February 2020 - 8:05AM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the
Company plans to issue its fourth-quarter and full-year 2019
financial results after the close of the market on Thursday,
February 20, 2019 and hold its investor conference call on the same
day, Thursday, February 20, 2019, at 5:00 p.m. ET to discuss its
financial results, business highlights, and outlook.
The conference call can be accessed by dialing 1-855-468-0611
(toll-free domestic) or 1-484-756-4332 (international). A live
audio webcast will be available in the "Investor Relations" section
of Anika's website, www.anikatherapeutics.com. An accompanying
slide presentation also can be accessed via the Anika Therapeutics
website. The call will be archived and accessible on the same
website shortly after its conclusion.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global,
integrated joint preservation and regenerative therapies company
based in Bedford, Mass. Anika is committed to delivering therapies
to improve the lives of patients across a continuum of care from
osteoarthritis pain management to joint preservation and
restoration. The company has more than two decades of global
expertise commercializing more than 20 products based on its
proprietary hyaluronic acid (HA) technology platform. For
more information about Anika, please visit
www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200206005030/en/
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer
investorrelations@anikatherapeutics.com For Media Inquiries: W2O
Group Jeremy Berrington, 312-241-1995 jberrington@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2024 to May 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From May 2023 to May 2024